ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
sergeimd
|
45 |
16K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
45
|
16K
|
0
|
|
ASX - By Stock
|
APX |
Re:
Ann: Pause in Trading
|
|
sergeimd
|
71 |
33K |
8 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
71
|
33K
|
8
|
|
ASX - By Stock
|
APX |
Re:
Ann: Institutional component of A$30m equity raising complete
|
|
sergeimd
|
23 |
8.3K |
4 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
23
|
8.3K
|
4
|
|
ASX - By Stock
|
AD8 |
Re:
Ann: FY22 Update
|
|
sergeimd
|
31 |
20K |
1 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
31
|
20K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
AVH Chart
|
|
sergeimd
|
711 |
259K |
8 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
711
|
259K
|
8
|
|
ASX - By Stock
|
BBN |
Re:
Ann: Trading Update and FY23 guidance
|
|
sergeimd
|
23 |
9.8K |
3 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
23
|
9.8K
|
3
|
|
ASX - By Stock
|
BBN |
Re:
Ann: Appointment of Managing Director & CEO
|
|
sergeimd
|
3 |
1.4K |
0 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
3
|
1.4K
|
0
|
|
ASX - By Stock
|
APX |
Re:
Ann: Completion of institutional component of equity raising
|
|
sergeimd
|
125 |
40K |
6 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
125
|
40K
|
6
|
|
ASX - By Stock
|
APX |
Re:
Ann: Completion of institutional component of equity raising
|
|
sergeimd
|
125 |
40K |
1 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
125
|
40K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Non-Renounceable Entitlement Offer Prospectus
|
|
sergeimd
|
16 |
12K |
0 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
16
|
12K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical to Announce Fourth Quarter 2022 Results
|
|
sergeimd
|
82 |
35K |
0 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
82
|
35K
|
0
|
|
ASX - By Stock
|
APX |
Re:
Ann: Appen expects non-cash asset impairment charge
|
|
sergeimd
|
85 |
34K |
3 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
85
|
34K
|
3
|
|
ASX - By Stock
|
APX |
Re:
APPEN and Artificial Intelligence media news
|
|
sergeimd
|
265 |
103K |
2 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
265
|
103K
|
2
|
|
ASX - By Stock
|
RZI |
Re:
Ann: January 2023 - Key Metrics
|
|
sergeimd
|
6 |
2.6K |
0 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
6
|
2.6K
|
0
|
|
ASX - By Stock
|
RZI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sergeimd
|
10 |
3.4K |
0 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
10
|
3.4K
|
0
|
|
ASX - By Stock
|
RZI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sergeimd
|
10 |
3.4K |
0 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
10
|
3.4K
|
0
|
|
ASX - By Stock
|
RZI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sergeimd
|
10 |
3.4K |
0 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
10
|
3.4K
|
0
|
|
ASX - By Stock
|
RZI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sergeimd
|
10 |
3.4K |
0 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
10
|
3.4K
|
0
|
|
ASX - By Stock
|
NEW |
Re:
Ann: Return of Capital - NEW
|
|
sergeimd
|
16 |
10K |
0 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
16
|
10K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
AVITA Medical achieves co-primary endpoints in updated RECELL trial
|
|
sergeimd
|
26 |
8.7K |
5 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
26
|
8.7K
|
5
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending September 2022 and Appendix 4C
|
|
sergeimd
|
8 |
3.6K |
1 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
8
|
3.6K
|
1
|
|
ASX - By Stock
|
BBN |
Re:
Medium/Long Term future of Baby Bunting?
|
|
sergeimd
|
82 |
46K |
1 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
82
|
46K
|
1
|
|
ASX - By Stock
|
BBN |
Re:
Medium/Long Term future of Baby Bunting?
|
|
sergeimd
|
82 |
46K |
6 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
82
|
46K
|
6
|
|
ASX - By Stock
|
BBN |
Re:
Ann: 2022 AGM - Chair and CEO address
|
|
sergeimd
|
6 |
3.1K |
1 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
6
|
3.1K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Enterprise Value
|
|
sergeimd
|
601 |
180K |
3 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
601
|
180K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Investor Presentation
|
|
sergeimd
|
2 |
1.5K |
2 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
2
|
1.5K
|
2
|
|
Charts
|
APX |
Re:
may I know if this stock can buy?
|
|
sergeimd
|
20 |
7.6K |
0 |
04/08/22 |
04/08/22 |
Charts
|
20
|
7.6K
|
0
|
|
Charts
|
APX |
Re:
may I know if this stock can buy?
|
|
sergeimd
|
20 |
7.6K |
0 |
04/08/22 |
04/08/22 |
Charts
|
20
|
7.6K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore Gains Access to US Federal Healthcare Facilities
|
|
sergeimd
|
7 |
3.5K |
1 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
7
|
3.5K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA to Announce Second Quarter 2022 Financial Results
|
|
sergeimd
|
48 |
21K |
0 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
48
|
21K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
News: OSX Osteopore Gains Access To U.S. Federal Healthcare Facilities
|
|
sergeimd
|
3 |
963 |
1 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
3
|
963
|
1
|
|
ASX - By Stock
|
RZI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sergeimd
|
6 |
1.9K |
1 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
6
|
1.9K
|
1
|
|
ASX - By Stock
|
RZI |
Re:
Ann: May 2022 - Key Metrics
|
|
sergeimd
|
16 |
9.1K |
1 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
16
|
9.1K
|
1
|
|
ASX - By Stock
|
RZI |
Re:
Ann: May 2022 - Key Metrics
|
|
sergeimd
|
16 |
9.1K |
0 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
16
|
9.1K
|
0
|
|
ASX - By Stock
|
FLC |
Re:
Chart
|
|
sergeimd
|
1.0K |
339K |
21 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
1.0K
|
339K
|
21
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Wins First MABR Plant Upgrade Contract In China
|
|
sergeimd
|
7 |
3.7K |
2 |
15/03/22 |
15/03/22 |
ASX - By Stock
|
7
|
3.7K
|
2
|
|
ASX - By Stock
|
APX |
Re:
Ann: Investor Presentation
|
|
sergeimd
|
247 |
112K |
0 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
247
|
112K
|
0
|
|
ASX - By Stock
|
APX |
Re:
Ann: Investor Presentation
|
|
sergeimd
|
247 |
112K |
1 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
247
|
112K
|
1
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Updated Investor Presentation
|
|
sergeimd
|
28 |
8.8K |
3 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
28
|
8.8K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending December 2021 and Appendix 4C
|
|
sergeimd
|
7 |
2.8K |
0 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
7
|
2.8K
|
0
|
|
ASX - By Stock
|
RZI |
Re:
Ann: Seven West Media Makes Strategic Investment in Raiz
|
|
sergeimd
|
21 |
6.5K |
4 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
21
|
6.5K
|
4
|
|
ASX - By Stock
|
RZI |
Re:
Ann: AGM Presentation
|
|
sergeimd
|
1 |
736 |
2 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
1
|
736
|
2
|
|
Charts
|
APX |
Re:
APX Charts
|
|
sergeimd
|
3.8K |
2.0M |
7 |
19/10/21 |
19/10/21 |
Charts
|
3.8K
|
2.0M
|
7
|
|
ASX - By Stock
|
APX |
Re:
Revenue spread
|
|
sergeimd
|
19 |
6.6K |
10 |
13/10/21 |
13/10/21 |
ASX - By Stock
|
19
|
6.6K
|
10
|
|
Charts
|
APX |
Re:
APX Charts
|
|
sergeimd
|
3.8K |
2.0M |
16 |
28/09/21 |
28/09/21 |
Charts
|
3.8K
|
2.0M
|
16
|
|
ASX - By Stock
|
APX |
Re:
Ann: Appen completes acquisition of Quadrant Global
|
|
sergeimd
|
118 |
43K |
4 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
118
|
43K
|
4
|
|
ASX - By Stock
|
RZI |
Re:
Ann: Board and Leadership Update
|
|
sergeimd
|
15 |
7.0K |
2 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
15
|
7.0K
|
2
|
|
ASX - By Stock
|
RZI |
Re:
Ann: Section 249D Notice - Update from the Board of Directors
|
|
sergeimd
|
35 |
13K |
0 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
35
|
13K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Acquisition in Sight
|
|
sergeimd
|
15 |
5.5K |
0 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
15
|
5.5K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore Sponsors Australian Patient Trials
|
|
sergeimd
|
7 |
2.3K |
2 |
04/09/21 |
04/09/21 |
ASX - By Stock
|
7
|
2.3K
|
2
|
|